The GLP-1 Forecast for 2024: Six Key Predictions
While GLP-1 medicines can be game changers in the management of obesity, we anticipate that they will also trigger a huge wave of cost increases for employers, payors, and our entire health system. This white paper identifies six GLP-1 trends for the upcoming year and corresponding takeaways for employers looking to craft a proactive utilization and care management approach.
Download the report today to find key recommendations for employers including:
- Find programs anchored to behavior and lifestyle change to help employees maintain weight loss and reduce long-term medication dependency
- Offer workforces a full-spectrum approach from prevention to clinical treatment
- Identify partners who invest in long-term studies to test the efficacy of their care models